NEW YORK (TheStreet) -- Pharmacy stocks are in a healthy position, said Jim Cramer during Monday's segment of CNBC's "Stop Trading" segment. 

Case in point: Rite Aid (RAD)  whose shares continue to climb -- up over 3% Monday -- after reporting a beat on revenue and earnings on Thursday. The company's generic drug reimbursement issues are now behind it and it has done a great job with its store remodelings, explained Cramer, the co-manager of the Action Alerts PLUS portfolio, and he thinks shares can "go much higher." 

RAD Chart
Rite Aid RAD data by YCharts

Cramer added Cowen & Company's Charles Rhyee upgraded Rite Aid to outperform from market perform and raised his price target to $8.50 from $6. 

The drugstore industry as a whole remains quite strong, Cramer said. CVS Health (CVS) has done a "remarkable job" since eliminating cigarette sales from its locations, he said. Walgreen  (WAG) , an AAP holding, reports earnings on Tuesday. 

-- Written by Bret Kenwell

Follow @BretKenwell

At the time of publication, Cramer's Action Alerts PLUS had a position in WAG.

More from Opinion

Why Ether and Ripple -- But Not Bitcoin -- Prices Might Come Under Pressure Soon

Why Ether and Ripple -- But Not Bitcoin -- Prices Might Come Under Pressure Soon

Daily Chatter: Here's Where the Markets Stand After Tuesday's Beating

Daily Chatter: Here's Where the Markets Stand After Tuesday's Beating

3 New Investing Myths That Must Be Busted

3 New Investing Myths That Must Be Busted

Why a Global Stock Market Crash Is Coming

Why a Global Stock Market Crash Is Coming

Sears CEO Eddie Lampert Looks Like He Is Sucking Company Dry

Sears CEO Eddie Lampert Looks Like He Is Sucking Company Dry